Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concernNicotiana benthamiana에서 생산된 SARS-CoV-2 변이체의 수용체 결합 도메인 단백질은 우려되는 변이체에 대한 중화 항체를 유도합니다Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] (alpha Alpha Beta binding domain booster vaccination Booster vaccine cloned COVID-19 cross-reactive Day Delta Delta variants dose Effective vaccines elicit Epsilon evaluated expression vector Fc fragment fragment of Gamma gene encoding health problem human IgG1 immune response immunized immunogenicity induce intramuscularly mutant Mutation Neutralizing antibodies neutralizing antibody Neutralizing antibody response neutralizing antibody responses Nicotiana benthamiana plant-produced recombinant protein produced Protein public health RBD RBD-Fc RBD-Fc fusion protein Receptor-binding domain Recombinant protein required respiratory SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 variant SARS-CoV-2 variants Severe acute respiratory syndrome significantly Spread subunit Subunit vaccine tested the receptor-binding domain the vaccine the vaccines transient expression Vaccine variant variant vaccine. variants variants of concern VOCs Wuhan [DOI] 10.1002/jmv.27881 PMC 바로가기 [Article Type] Article
Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodiesAnti-SARS-CoV-2 IgG 및 중화항체의 초고감도 검출을 위한 스마트폰 기반 양자점 측방유동 면역분석 스트립 개발Article Published on 2022-08-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] affected angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 anti-SARS-CoV-2 IgG Antigen Blood donors common cold COVID-19 cross-reaction development diagnosed healthy blood donors human serum IgG immunoassay Inactivated vaccine Inactivated Vaccines individual Influenza influenza B inoculated lateral flow immunoassay Neutralizing antibodies neutralizing antibody nucleic acid nucleic acid test pandemic Patient patients with influenza platform populations positive proportion protective effect quantum Quantum dot reaction Receptor binding domain SARS-CoV-2 SARS-CoV-2 spike protein Smartphone Spike protein subunit vaccines the SARS-CoV-2 the vaccine the vaccines two patients Vaccine virus-neutralizing antibody was used Whole blood [DOI] 10.1016/j.ijid.2022.04.042 PMC 바로가기 [Article Type] Article
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trialChAdOx1 nCoV-19 또는 BNT162b2 2회 접종 및 BNT162b2(COV-BOOST) 3차 접종 후 4차 접종으로 제공된 BNT162b2 및 mRNA-1273 COVID-19 백신의 안전성, 면역원성 및 반응성: 다기관, 맹검, 단계 2, 무작위 시험Clinical Trial Published on 2022-08-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 1:1 95% CI adverse event All participants analysed anti-spike protein IgG assigned blinded block size BNT162b2 boost booster Booster vaccine cellular Cellular and humoral immunity Cellular immune response ChAdOx1 nCoV-19 computer-generated Concentration Controlled trial country COV-BOOST COVID-19 COVID-19 vaccine COVID-19 vaccines dose doses Effectiveness ELISA ELISPOT Endpoint enrolled fatigue female Fold change Fold changes force geometric geometric mean groups Humoral immunity immunogenicity Intramuscular injection IQR ISRCTN Laboratory Local male median age median interval Moderna modified intention-to-treat mRNA mRNA-1273 mRNA-1273 booster mRNA-1273 COVID-19 vaccine multicentre of BNT162b2 outcome participant peak per-protocol population Pfizer-BioNTech Phase 2 random randomisation list randomised controlled trial Randomised trial Randomly reactogenicity receive Registered reported representing response Safety SARS-CoV-2 screened Serious Adverse Event seronegative participant seronegative participants serostatus Seven significant increase statistician T-cell Response T-cell responses Task Force the vaccine the vaccines titre treatment allocation Trial upper arm Vaccine variant were assessed wild-type [DOI] 10.1016/S1473-3099(22)00271-7 PMC 바로가기 [Article Type] Clinical Trial
Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis사망 예방을 위한 SARS-CoV-2 백신의 효능 및 효과: 체계적인 검토 및 메타 분석을 위한 프로토콜Article Published on 2022-07-282022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, meta-analysis, SARS, [키워드] adverse event all-cause mortality analyzed approved assessment Bia calculated case-control studies case-control study Cohort controlled trials COVID-19 death deaths effective Effectiveness Efficacy Egger eligible Evidence exploratory for inclusion forest plot forest plots funnel plot hazard hazard ratios heterogeneity Hospitalization incident independent intervals Intervention Meta-analysis Mortality Observational data outcome Placebo Prevent Primary outcome PROSPERO protocol Publication bia publication bias randomized control trial Randomized controlled trials RCT Record reducing Registered risk reduction SARS-CoV-2 vaccine SARS-CoV-2 vaccines Secondary outcomes Severe case severe cases statistical statistical test systematic review the vaccine the vaccines university vaccination Vaccination Status Vaccine visual inspection York [DOI] 10.1371/journal.pone.0265414 PMC 바로가기 [Article Type] Article
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsmRNA-1273 및 BNT162b2 COVID-19 백신은 Fc 매개 효과기 기능에 차이가 있는 항체를 유도합니다Article Published on 2022-05-182022-09-11 Journal: Science Translational Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody approved binding BNT162b2 cell activation Cohort Concentration coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Efficacy elicit epitope evade Fc-mediated effector function function functional functional capacity Hospital staff humoral immune response humoral immune responses IgA immune response immune responses Killer cell morbidity morbidity and mortality mRNA mRNA vaccines mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines N-terminal N-terminal domain natural killer natural killer cell neutralization Neutralizing antibodies neutrophil phagocytosis potential differences protective immunity RBD Receptor binding domain recipient recipients reduced Region respiratory responses robust SARS-CoV-2 the vaccine the vaccines These data Vaccine Vaccines variants variants of concern Variation Viral viral variant Viral variants wake wild-type [DOI] 10.1126/scitranslmed.abm2311 PMC 바로가기 [Article Type] Article
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies백신 유도 및 치료 항체에 의한 중화에 대한 SARS-CoV-2 Omicron 변이체의 내성 증가Article Published on 2022-04-012022-09-11 Journal: EBioMedicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] antibody Antibody neutralization applied benefit BNT162b2 booster concern decrease disease severity Donor donors effective Effectiveness Efficacy Emergency use highlight immunization Increased incubated lentivirus Lilly luciferase luciferase activity luminometer maintain mapped Moderna monoclonal antibodies monoclonal antibody monoclonal antibody therapies monoclonal antibody therapy mutated neutralization Neutralizing NIH obstacle omicron Omicron variant Pfizer preventing infection PROTECT protein structure pseudotype pseudotyped lentiviruses Regeneron Resistance mutation resistance mutations SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant sera serum Sotrovimab Spike protein T cells target cells the vaccine the vaccines therapeutic Therapies therapy titre Vaccine vaccine efficacy variant was measured [DOI] 10.1016/j.ebiom.2022.103944 PMC 바로가기 [Article Type] Article
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later1년 후 사라예보, 보스니아 헤르체고비나 주 내 SARS-CoV-2에 대한 항체 혈청 유병률Article Published on 2022-03-312022-09-11 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, [키워드] age anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody electrochemiluminescence immunoassay Frequency General population gradually increased group help highest inaccessible individual individuals local public health lowest measure median men Older Pandemics positive Prevalence PROTECT provided quantified Reinfection resource SARS-CoV-2 seropositive individual seropositive individuals Seropositivity Spread the vaccine the vaccines vaccination Vaccine development women [DOI] 10.1371/journal.pone.0265431 PMC 바로가기 [Article Type] Article
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variantsSARS-CoV-2 및 변이체에 대한 강력한 예방 및 치료 효능을 지닌 동급 최초의 삼중특이성 VHH-Fc 기반 항체Article Published on 2022-03-092022-09-10 Journal: Scientific Reports [Category] MERS, SARS, 바이오마커, 변종, [키워드] ACE-2 addition antibody Antibody therapy cellular characterized comparable COVID-19 cases COVID-19 pandemic COVID-19 vaccination death Delta demonstrated distribution Drug development Efficacy Efficacy and safety epitope evaluated feature greatly reduce hospitalizations humanized Immunity in vitro in vivo intranasal lead Measures multiple epitope omicron parameter PBS prevented Prophylactic Prophylaxis provided reduced reported safety profile SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 mutants shown tested the vaccine the vaccines therapeutic efficacy Treatment treatment for COVID-19 variant Viral Viral load viral loads while [DOI] 10.1038/s41598-022-07952-4 PMC 바로가기 [Article Type] Article
Dynamical regulations on mobility and vaccinations for controlling COVID-19 spreadCovid-19 스프레드 제어를위한 이동성 및 예방 접종에 대한 동적 규정Article Published on 2022-03-032022-09-10 Journal: Scientific Reports [Category] MERS, SARS, 변종, [키워드] country COVID-19 Critical decrease disease transmission Diseases document dropping Effectiveness explain Forecasting further Infectious diseases prototype Regulation reproductive required Spread the vaccine the vaccines Transmission vaccination variants [DOI] 10.1038/s41598-022-07371-5 PMC 바로가기 [Article Type] Article
The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay신속한 SARS-CoV-2 항원 검출 분석에 의한 태국의 사립 대학 학생 및 직원의 COVID-19 감염 유병률Research Article Published on 2022-03-032022-09-10 Journal: Journal of Environmental and Public Health [Category] MERS, SARS, 치료기술, [키워드] affected Antigen AstraZeneca CoronaVac Course COVID-19 COVID-19 crisis COVID-19 pandemic detection Factor implementation individual infection rate initial symptom initial symptoms management not differ Other Private Rapid Research risk Risk management SARS-CoV-2 screening test screening tests staff student Suspension the vaccines university vaccination Vaccine Vaccines were infected [DOI] 10.1155/2022/2350522 PMC 바로가기 [Article Type] Research Article